| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | NEUTRAL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.07▼ | 5.04▲ | 5.03▲ | 4.97▲ | 5.25▼ |
| MA10 | 5.06▼ | 5.01▲ | 5.00▲ | 5.06▼ | 5.13▼ |
| MA20 | 5.05▲ | 4.99▲ | 4.99▲ | 5.11▼ | 4.68▲ |
| MA50 | 5.01▲ | 4.96▲ | 4.98▲ | 5.02▲ | 3.76▲ |
| MA100 | 4.99▲ | 5.03▲ | 5.08▼ | 4.56▲ | 3.86▲ |
| MA200 | 4.98▲ | 5.09▼ | 5.18▼ | 3.87▲ | 3.50▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | 0.009▲ | 0.011▲ | -0.029▼ | -0.006▼ |
| RSI | 52.231▲ | 56.657▲ | 54.425▲ | 49.565▼ | 55.524▲ |
| STOCH | 67.793 | 87.460▲ | 69.489 | 27.940 | 59.064 |
| WILL %R | -57.143 | -20.000▲ | -18.182▲ | -68.608 | -58.242 |
| CCI | 36.207 | 123.469▲ | 112.752▲ | -32.839 | -30.313 |
|
Monday, November 10, 2025 02:02 AM
Puma Biotechnology has one approved drug, strong cash, and is developing alisertib with key ALISCA trial readouts in 1H 2026. Learn why PBYI stock is a buy.
|
|
Sunday, November 09, 2025 04:50 AM
Puma Biotechnology, Inc. ( NASDAQ:PBYI ) just released its latest quarterly results and things are looking bullish.
|
|
Thursday, November 06, 2025 09:12 PM
Puma Biotechnology Inc (PBYI) reports increased US sales of Neuralinks and anticipates becoming debt-free by mid-2026, despite challenges in international revenue streams.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 18/11/25 | 4.97 | 5.09 | 4.862 | 5.06 | 528,409 |
| 17/11/25 | 4.85 | 5.0999 | 4.85 | 4.96 | 515,961 |
| 14/11/25 | 4.85 | 5.015 | 4.76 | 4.89 | 460,949 |
| 13/11/25 | 4.93 | 4.97 | 4.81 | 4.95 | 657,161 |
| 12/11/25 | 5.11 | 5.16 | 4.89 | 4.99 | 670,356 |
| 11/11/25 | 4.75 | 5.20 | 4.575 | 5.19 | 1,220,308 |
| 10/11/25 | 5.99 | 6.12 | 4.70 | 4.73 | 1,904,655 |
| 07/11/25 | 5.33 | 6.04 | 5.0407 | 5.99 | 2,367,226 |
| 06/11/25 | 5.01 | 5.09 | 4.88 | 4.90 | 454,118 |
| 05/11/25 | 4.91 | 5.07 | 4.80 | 4.945 | 506,624 |
|
|
||||
|
|
||||
|
|